These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29581631)

  • 1. Dystrophin Exon 29 Nonsense Mutations Cause a Variably Mild Phenotype.
    Moore RS; Tirupathi S; Herron B; Sands A; Morrison PJ
    Ulster Med J; 2017 Sep; 86(3):185-188. PubMed ID: 29581631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy.
    Okubo M; Noguchi S; Hayashi S; Nakamura H; Komaki H; Matsuo M; Nishino I
    Hum Genet; 2020 Feb; 139(2):247-255. PubMed ID: 31919629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials.
    Anthony K; Cirak S; Torelli S; Tasca G; Feng L; Arechavala-Gomeza V; Armaroli A; Guglieri M; Straathof CS; Verschuuren JJ; Aartsma-Rus A; Helderman-van den Enden P; Bushby K; Straub V; Sewry C; Ferlini A; Ricci E; Morgan JE; Muntoni F
    Brain; 2011 Dec; 134(Pt 12):3547-59. PubMed ID: 22102647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene.
    Flanigan KM; Dunn DM; von Niederhausern A; Soltanzadeh P; Howard MT; Sampson JB; Swoboda KJ; Bromberg MB; Mendell JR; Taylor LE; Anderson CB; Pestronk A; Florence JM; Connolly AM; Mathews KD; Wong B; Finkel RS; Bonnemann CG; Day JW; McDonald C; ; Weiss RB
    Hum Mutat; 2011 Mar; 32(3):299-308. PubMed ID: 21972111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-level dystrophin expression attenuating the dystrophinopathy phenotype.
    Waldrop MA; Gumienny F; El Husayni S; Frank DE; Weiss RB; Flanigan KM
    Neuromuscul Disord; 2018 Feb; 28(2):116-121. PubMed ID: 29305136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients?
    Yokota T; Duddy W; Echigoya Y; Kolski H
    Expert Opin Biol Ther; 2012 Sep; 12(9):1141-52. PubMed ID: 22650324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
    Toh ZY; Thandar Aung-Htut M; Pinniger G; Adams AM; Krishnaswarmy S; Wong BL; Fletcher S; Wilton SD
    PLoS One; 2016; 11(1):e0145620. PubMed ID: 26745801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense.
    Aartsma-Rus A; Janson AA; Kaman WE; Bremmer-Bout M; van Ommen GJ; den Dunnen JT; van Deutekom JC
    Am J Hum Genet; 2004 Jan; 74(1):83-92. PubMed ID: 14681829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy.
    Béroud C; Tuffery-Giraud S; Matsuo M; Hamroun D; Humbertclaude V; Monnier N; Moizard MP; Voelckel MA; Calemard LM; Boisseau P; Blayau M; Philippe C; Cossée M; Pagès M; Rivier F; Danos O; Garcia L; Claustres M
    Hum Mutat; 2007 Feb; 28(2):196-202. PubMed ID: 17041910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping.
    Anthony K; Arechavala-Gomeza V; Ricotti V; Torelli S; Feng L; Janghra N; Tasca G; Guglieri M; Barresi R; Armaroli A; Ferlini A; Bushby K; Straub V; Ricci E; Sewry C; Morgan J; Muntoni F
    JAMA Neurol; 2014 Jan; 71(1):32-40. PubMed ID: 24217213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
    Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
    Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.
    Walmsley GL; Arechavala-Gomeza V; Fernandez-Fuente M; Burke MM; Nagel N; Holder A; Stanley R; Chandler K; Marks SL; Muntoni F; Shelton GD; Piercy RJ
    PLoS One; 2010 Jan; 5(1):e8647. PubMed ID: 20072625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.
    Hoffman EP
    Acta Myol; 2020 Dec; 39(4):179-186. PubMed ID: 33458572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Becker muscular dystrophy with widespread muscle hypertrophy and a non-sense mutation of exon 2.
    Witting N; Duno M; Vissing J
    Neuromuscul Disord; 2013 Jan; 23(1):25-8. PubMed ID: 22939275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy.
    Nakamura A
    J Hum Genet; 2017 Oct; 62(10):871-876. PubMed ID: 28566768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients.
    Helderman-van den Enden AT; Straathof CS; Aartsma-Rus A; den Dunnen JT; Verbist BM; Bakker E; Verschuuren JJ; Ginjaar HB
    Neuromuscul Disord; 2010 Apr; 20(4):251-4. PubMed ID: 20153965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical treatment enhances skipping of a mutated exon in the dystrophin gene.
    Nishida A; Kataoka N; Takeshima Y; Yagi M; Awano H; Ota M; Itoh K; Hagiwara M; Matsuo M
    Nat Commun; 2011; 2():308. PubMed ID: 21556062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exons 45-55 Skipping Using Mutation-Tailored Cocktails of Antisense Morpholinos in the DMD Gene.
    Echigoya Y; Lim KRQ; Melo D; Bao B; Trieu N; Mizobe Y; Maruyama R; Mamchaoui K; Tanihata J; Aoki Y; Takeda S; Mouly V; Duddy W; Yokota T
    Mol Ther; 2019 Nov; 27(11):2005-2017. PubMed ID: 31416775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of exon 26 of the dystrophin gene is associated with a mild Becker muscular dystrophy phenotype.
    Witting N; Duno M; Vissing J
    Acta Myol; 2011 Dec; 30(3):182-4. PubMed ID: 22616200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-terminal truncated dystrophin identified in skeletal muscle of an asymptomatic boy with a novel nonsense mutation of the dystrophin gene.
    Suminaga R; Takeshima Y; Wada H; Yagi M; Matsuo M
    Pediatr Res; 2004 Nov; 56(5):739-43. PubMed ID: 15371569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.